Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2018 | The key unanswered question in lung cancer?

Alastair Greystoke, David Baldwin, James Spicer, Jeanette Dickson, Kenneth O'Byrne, Neal Navani, Paul Beckett, Sanjay Agrawal and Solange Peters • 25 Jan 2018
BTOG 2018
Lung Cancer Non-Small Cell Lung Cancer Small Cell Lung Cancer

At the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, we asked a range of experts what they thought the key unanswered question in lung cancer is currently. They were all in agreement that there are a range of issues to address, but each speaker had their own take on the question. Ranging from disease biology to early diagnosis and policy, see what the experts thought.

More from Alastair Greystoke

6:20
Solid tumor genomic testing in the UK: challenges and solutions
Alastair Greystoke • 28 Apr 2023
1:51
NHS England: a pilot ctDNA study to track patient responses to novel genomic targets
Alastair Greystoke • 27 Apr 2023
5:59
Deciphering an NGS report in lung cancer
Alastair Greystoke • 24 Jan 2022
3:34
Strategies to improve biomarker testing in the UK
Alastair Greystoke • 24 Jan 2022

More from David Baldwin

3:36
Facilitating the decision-making process for patients during lung cancer screening
David Baldwin • 29 Aug 2023
1:33
Strategies for ensuring the cost-effectiveness of lung cancer screening in the UK
David Baldwin • 29 Aug 2023
1:32
Advancements in the UK’s national screening programme for lung cancer
David Baldwin • 29 Aug 2023
1:26
Highlights from WCLC 2022: CT screening
David Baldwin • 7 Aug 2022

More from James Spicer

2:06
TILs: Precision medicine in NSCLC
James Spicer • 26 Apr 2023
2:26
Turning genomic advances into treatment options
James Spicer • 26 Apr 2023
2:22
Tumor mutational burden: an emerging biomarker to guide immunotherapy
James Spicer • 26 Oct 2018
3:02
Osimertinib for treating non-small cell lung cancer
James Spicer • 26 Oct 2018

More from Jeanette Dickson

2:24
BTOG 2018 speaker highlights
Alastair Greystoke et al. • 24 Jan 2018
1:41
The current landscape of radiotherapy services in the UK
Jeanette Dickson • 26 Jan 2018
0:43
Lung cancer care: the technology is there, but what else is needed?
Jeanette Dickson • 26 Jan 2018
0:32
The importance of BTOG for multiprofessional communication
Jeanette Dickson • 26 Jan 2018

More from Kenneth O'Byrne

5:55
Checkpoint inhibitor resistance in lung cancer
Kenneth O'Byrne • 30 Jan 2020
3:03
The tumor microenvironment: lung cancer
Kenneth O'Byrne • 30 Jan 2020
2:33
Concurrent immunotherapy in SCLC
Kenneth O'Byrne • 31 Jan 2020
2:28
Painting the lung cancer cell picture
Kenneth O'Byrne • 30 Jan 2020

More from Neal Navani

1:55
National Lung Cancer Audit (NLCA) 2023
Neal Navani • 28 Apr 2023
2:38
"Bridging the Gap": 3 key recommendations from UKLCC report on inequalities in lung cancer care
Neal Navani • 3 Nov 2022
2:22
Equal access to care is a key challenge in lung cancer
Neal Navani • 3 Nov 2022
1:56
"Bridging the Gap": How the National Lung Cancer Audit aims to tackle health inequalities
Neal Navani • 3 Nov 2022

More from Sanjay Agrawal

2:02
Quitting: is vaping effective for patients?
Sanjay Agrawal • 30 Jan 2020
2:21
The vaping-related lung injury epidemic
Sanjay Agrawal • 30 Jan 2020
2:24
BTOG 2018 speaker highlights
Alastair Greystoke et al. • 24 Jan 2018
0:37
The recording and referral of smokers in the UK: an area for improvement
Sanjay Agrawal • 25 Jan 2018

More from Solange Peters

2:01
Unanswered questions on immunotherapy for lung cancer
Solange Peters • 11 Sep 2022
3:09
ESMO 2022: Highlights from the Presidential Symposium
Solange Peters • 11 Sep 2022
3:18
Subgroup analysis of PEARLS/KEYNOTE-091: PD-L1 expression and outcomes of pembrolizumab
Solange Peters • 11 Sep 2022
2:42
Aligning the educational resources put out by ESMO
Solange Peters • 30 Sep 2019

Related Videos

2:09
Is there a role for radiotherapy in extensive-stage SCLC?
Clive Peedell • 18 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
3:03
BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies
Sanjay Popat • 19 Apr 2024
1:03
The benefits of liquid biopsies for lung cancer in the community setting
Deepti Behl • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals